Prenetics Global PRE 深滬

已收盤 02-06 16:00:00 美东时间

19.24

+1.530

+8.64%

華盛通

立即下載

最高19.44
今開17.50
成交量 19.37万股
最低 17.00
昨收 17.71
總市值 3.24亿
52周最高 20.89
市盈率 ^靜 --
換手率 1.15%
52周最低 3.0947
委比 50.09%
總股本 1682.84万
歷史最高 131.25
量比 0.88
振幅 13.78%
歷史最低 2.85
每手 1
風險率 4.56%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

Prenetics Global Sells Europa Sports Partners In All-Stock Transaction Valued At Up To $13M

Company Continues Portfolio Optimization on the Heels of Successful $72 million ACT Genomics saleCompany Maintains Strong Balance Sheet with over $70 million in Cash and Cash Equivalents, 510 BTC and Zero Debt,

01-06 21:09
Prenetics Global Enters Exchange Agreements For Class A, B Warrants, Reporting ~86.7% Participation

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced an update to its previously announced

01-05 21:02
Prenetics Provides Update on Voluntary Warrant Exchange Program, Reaching 86.7% Participation

Prenetics Global Limited announced that 86.7% of its Class A and Class B warrants issued in October 2025 have been exchanged for Class C warrants, reducing the total warrants from 5.45 million to 3.08 million. This exchange lowers potential dilution impact from 32.3% to 18.3% of total outstanding shares and simplifies the capital structure, enhancing the Company's investability. The new Class C warrants have an exercise price of $18.00, a two-yea...

01-05 13:00
Prenetics halts Bitcoin purchases to focus on consumer health brand, IM8

Health sciences company Prenetics (PRE) announced on Tuesday that it would no longer allocate its existing capital or any new capital for purchasing additional Bitcoin (BTC-USD) investments as it focu...

2025-12-30 22:18
Prenetics Launches Voluntary Warrant Exchange Program, Representing ~83.4% Of Outstanding Class A and B Warrants; Aims To Simplify Capital Structure, Reduce Potential Dilution By Up To 50%, Consolidate Legacy Warrants Into Single Class C Warrants

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced that it has entered into warrant exchange

2025-12-23 22:11
Prenetics Enters Into Warrant Exchange Agreements With Warrant Holders, Strengthening Capital Structure

Prenetics Global Limited has launched a voluntary warrant exchange program to simplify its capital structure and reduce future dilution. The program, supported by major shareholders, involves exchanging approximately 83.4% of its Class A and Class B warrants for new Class C warrants. The new warrants have a lower exercise price, a shorter term, and a forced-redemption feature. This exchange is expected to reduce warrant overhang by up to 50% and ...

2025-12-23 14:08
Prenetics Announces Upcoming Conference Participation

Prenetics Global Limited (NASDAQ: PRE) announced its participation in two upcoming investor conferences: The Benchmark Company’s 14th Annual Discovery One-on-One Conference on December 4, 2025, in New York City, and Sidoti’s Year End Virtual Investor Conference on December 10-11, 2025. CEO Danny Yeung and CFO Stephen Lo will attend, with Yeung delivering a presentation at Sidoti’s event. The presentation will be available for viewing at the provi...

2025-11-25 13:49
Prenetics executives buy $1.45M in company stock

Prenetics (PRE) executives collectively purchased 111,911 shares for about $1.45M during the company’s trading window. Chief executive officer Danny Yeung bought 40,118 shares for roughly $502,000 at ...

2025-11-24 20:42
Prenetics Global's Executives Acquire ~$1.4M Common Shares

Prenetics Global Limited (NASDAQ:PRE) ("Prenetics" or the "Company"), the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today

2025-11-24 20:33
Prenetics Executives Announce Open Market Share Purchases Totaling Approx. $1.45 Million

Prenetics Global Limited's executive leadership team purchased a total of 111,911 shares of the company's common stock during the designated trading window, amounting to approximately $1,446,887. CEO Danny Yeung emphasized the team's conviction in Prenetics' long-term vision, highlighting IM8's rapid growth and the company's Bitcoin-treasury strategy. As a leader in health-tech and longevity, Prenetics is paving the way for future growth through ...

2025-11-24 12:30

派息除權日	每股總股息	派息日期
2016-02-17	0.70	2016-03-01
2015-11-04	0.70	2015-12-01
2015-08-05	0.70	2015-09-01
2015-05-06	0.70	2015-06-01
2015-02-11	0.70	2015-02-27
2014-11-18	0.67	2014-12-01
2014-08-14	0.67	2014-08-29
2014-05-15	0.67	2014-05-30
2014-02-13	0.67	2014-02-28
2013-11-14	0.64	2013-11-29
2013-08-15	0.64	2013-08-30
2013-05-16	0.64	2013-05-31
2013-02-14	0.64	2013-03-01
2012-11-15	0.62	2012-11-30
2012-08-16	0.62	2012-08-31
2012-05-17	0.62	2012-06-01
2012-02-15	0.62	2012-03-01
2011-11-16	0.60	2011-12-01
2011-08-17	0.60	2011-09-01
2011-05-18	0.60	2011-06-01
2011-02-16	0.55	2011-03-01
2010-11-17	0.55	2010-12-01
2010-08-18	0.50	2010-09-01
2010-05-19	0.50	2010-06-01
2010-02-17	0.50	2010-03-01
2009-11-18	0.47	2009-12-01
2009-08-19	0.47	2009-09-01
2009-05-20	0.47	2009-06-01
2009-02-18	0.47	2009-03-02
2008-11-19	0.46	2008-12-01
2008-08-19	0.46	2008-08-29
2008-05-21	0.46	2008-06-02
2008-02-20	0.46	2008-03-03
2007-11-20	0.43	2007-12-03
2007-08-17	0.43	2007-08-31
2007-05-18	0.43	2007-06-01
2007-02-14	0.43	2007-03-01
2006-11-17	0.40	2006-12-01
2006-08-18	0.40	2006-09-01
2006-05-18	0.40	2006-06-01
2006-02-15	0.40	2006-03-01
2005-11-17	0.38	2005-12-01
2005-08-18	0.38	2005-09-01
2005-05-18	0.38	2005-06-01
2005-02-16	0.38	2005-03-01
2004-11-17	0.34	2004-12-01
2004-08-18	0.34	2004-09-01
2004-05-19	0.34	2004-06-01
2004-02-18	0.34	2004-03-01
2003-11-19	0.31	2003-12-01
2003-08-20	0.31	2003-09-02
2003-05-21	0.29	2003-06-02
2003-02-19	0.29	2003-03-03
2002-11-20	0.29	2002-12-02
2002-08-21	0.29	2002-09-03
2002-05-22	0.29	2002-06-03
2002-02-14	0.28	2002-03-01
2001-11-16	0.28	2001-11-30
2001-08-17	0.28	2001-08-31
2001-05-18	0.28	2001-06-01
2001-02-14	0.26	2001-03-01
2000-11-17	0.26	2000-12-01
2000-08-18	0.26	2000-09-01
2000-05-18	0.26	2000-06-01
2000-02-16	0.26	2000-03-01
1999-11-17	0.25	1999-12-01
1999-08-18	0.25	1999-09-01
1999-05-19	0.25	1999-06-01
1999-02-17	0.25	1999-03-01
1998-11-18	0.22	1998-12-01
1998-10-28	0.22	1998-12-01
1998-08-19	0.22	1998-09-01
1998-05-20	0.22	1998-06-01
1998-02-18	0.22	1998-03-02
1997-11-19	0.18	1997-12-01
1997-08-20	0.18	1997-09-02
1997-05-21	0.18	1997-06-02
1997-02-19	0.18	1997-03-03
1996-11-14	0.15	1996-12-02
1996-08-13	0.15	1996-09-03
1996-05-13	0.15	1996-06-03
1996-02-13	0.15	1996-03-01
1995-11-13	0.13	1995-12-01
1995-08-11	0.13	1995-09-01
1995-05-09	0.10	1995-06-01
1995-02-09	0.10	1995-03-01
1994-11-08	0.10	1994-12-01
1994-08-09	0.10	1994-09-01
1994-05-10	0.10	1994-06-01
1994-02-09	0.10	1994-03-01

公司名稱	Artisan Acquisition Corp.
行業分類	Financial Conglomerates
業務描述	Prenetics Global Ltd. is a health sciences company, which engages in providing consumer health products and services. The firm offers scientifically formulated supplements under the IM8 brand, sports nutrition products under the Europa platform, and direct-to-consumer DNA tests through the CircleDNA brand. It is also involved in establishing a Bitcoin treasury for the exploration of applications within the healthcare ecosystem. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and has dual headquartered in Charlotte, the United States and Hong Kong.

Prenetics Global PRE 深 滬

19.24

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

Prenetics Global PRE 深滬